Dr. Wada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr E13
Salt Lake City, UT 84132Phone+1 801-581-2955Fax+1 801-587-6346
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2009 - 2012- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 2007 - 2008
University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Saint Joseph HospitalResidency, Internal Medicine, 2002 - 2005
University of Hawaii, John A. Burns School of MedicineClass of 2002
Certifications & Licensure
AZ State Medical License 2019 - 2026
HI State Medical License 2020 - 2026
UT State Medical License 2004 - 2026
ID State Medical License 2015 - 2024
MN State Medical License 2007 - 2012
CO State Medical License 2002 - 2005- American Board of Dermatology Dermatology
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
Clinical Trials
- ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome Start of enrollment: 2016 Oct 01
Roles: Contact
Publications & Presentations
PubMed
- Erythematous papules and umbilicated pustules on a man with proctitis.Garett J Grant, David A Wada, Lauren M Madigan
International Journal of Dermatology. 2023-08-01 - 1 citationsFolliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions.James Abbott, Jessica Corean, Ashley M Snyder, Scott R Florell, Rodney Miles
Skin Health and Disease. 2023-06-01 - 5 citationsFeasibility of personalized circulating tumor DNA detection in stage II and III melanoma.Elise K Brunsgaard, Tawnya L Bowles, Elliot A Asare, Kenneth Grossmann, Kenneth M Boucher
Melanoma Research. 2023-06-01
Press Mentions
Desmoplastic Melanoma Responds to PD-1 Blockade ImmunotherapyMay 26th, 2022
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
